CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-06 | Elston George Chief Financial Officer | Option exercise | +15,285 | 73,374 | ||
| 2025-01-06 | Elston George Chief Financial Officer | Shares withheld for taxes | −4,808 | $8.68 | $42K | 68,566 |
| 2025-01-06 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −15,285 | 14,715 | ||
| 2025-01-06 | Lurker Nancy Director | Option exercise | +75,134 | 185,436 | ||
| 2025-01-06 | Lurker Nancy Director | Option exercise · Restricted Stock Units | −75,134 | 75,133 | ||
| 2025-01-06 | Duker Jay S. President and CEO | Option exercise | +20,794 | 78,814 | ||
| 2025-01-06 | Duker Jay S. President and CEO | Shares withheld for taxes | −6,108 | $8.68 | $53K | 72,706 |
| 2025-01-06 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −20,794 | 39,206 | ||
| 2025-01-05 | Elston George Chief Financial Officer | Option exercise | +15,000 | 63,356 | ||
| 2025-01-05 | Elston George Chief Financial Officer | Shares withheld for taxes | −5,267 | $8.26 | $44K | 58,089 |
| 2025-01-05 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −15,000 | 30,000 | ||
| 2025-01-05 | Lurker Nancy Director | Option exercise | +12,667 | 110,302 | ||
| 2025-01-05 | Lurker Nancy Director | Option exercise · Restricted Stock Units | −12,667 | 25,333 | ||
| 2025-01-05 | Landis John B. Director | Option exercise | +10,000 | 21,400 | ||
| 2025-01-05 | Landis John B. Director | Option exercise · Restricted Stock Units | −10,000 | 0 | ||
| 2025-01-05 | Duker Jay S. President and CEO | Option exercise | +30,000 | 68,027 | ||
| 2025-01-05 | Duker Jay S. President and CEO | Shares withheld for taxes | −10,007 | $8.26 | $83K | 58,020 |
| 2025-01-05 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −30,000 | 60,000 | ||
| 2025-01-03 | Hassan Fred Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-03 | Zaderej Karen L. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 7 of 18 · 352 trades